曲妥珠单抗每三周方案联合紫杉醇治疗HER-2阳性转移性乳腺癌的药代动力学、安全性及有效性研究

    Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome

    /

    返回文章
    返回